Patents-Review.com
🔗 Permalink
Assignee profile:

Apotex Inc.

City:

Toronto, Ontario

Country:

Canada

Published Applications:

19

Last publication date:

2020-02-13

Patent Grants:

19

Last grant date:

2020-10-13

Top Inventors for applications by Apotex Inc.

These are the the leading inventors for applications assigned to Apotex Inc.:

Recent patent applications by Apotex Inc.

Apotex Inc. based in Toronto, Ontario, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-02-13 ✅ Patent 10,800,787 granted on 2020-10-13
US20200048264A1
Chemistry; metallurgy

Process for the preparation of acalabrutinib

 #2 | 2020-01-02 ✅ Patent 10,611,772 granted on 2020-04-07
US20200002343A1
Chemistry; metallurgy

Crystalline form of Ribociclib succinate

 #3 | 2019-11-14 ✅ Patent 10,723,739 granted on 2020-07-28
US20190345163A1
Chemistry; metallurgy

Processes for the preparation of Ribociclib and intermediates thereof

 #4 | 2019-11-14 ✅ Patent 10,632,107 granted on 2020-04-28
US20190343815A1
Human necessities

Crystalline forms of benzoquinoline inhibitors of vesicular monoamine transporter 2

 #5 | 2019-08-01 ✅ Patent 10,662,178 granted on 2020-05-26
US20190233400A1
Chemistry; metallurgy

Crystalline form of Olaparib

 #6 | 2019-05-16 ✅ Patent 10,407,396 granted on 2019-09-10
US20190144397A1
Chemistry; metallurgy

Crystalline form of selexipag

 #7 | 2019-04-25 ✅ Patent 10,556,887 granted on 2020-02-11
US20190119257A1
Chemistry; metallurgy

Processes for the preparation of Veliparib and intermediates thereof

 #8 | 2019-03-28 ✅ Patent 10,487,059 granted on 2019-11-26
US20190092734A1
Chemistry; metallurgy

Crystalline form of Eluxadoline

 #9 | 2018-06-07 ✅ Patent 10,183,024 granted on 2019-01-22
US20180153895A1
Human necessities

Crystalline forms of ibrutinib

 #10 | 2017-12-14 ✅ Patent 9,944,616 granted on 2018-04-17
US20170355688A1
Chemistry; metallurgy

Processes for the preparation of Tasimelteon and intermediates thereof

 #11 | 2017-08-24 ✅ Patent 10,016,423 granted on 2018-07-10
US20170239247A1
Human necessities

Solid forms of nilotinib hydrochloride

 #12 | 2017-03-30 ✅ Patent 9,938,240 granted on 2018-04-10
US20170088518A1
Chemistry; metallurgy

Fluorinated derivatives of 3-hydroxypyridin-4-ones

 #13 | 2017-03-02 ✅ Patent 9,776,970 granted on 2017-10-03
US20170057923A1
Chemistry; metallurgy

Bosutinib forms and preparation methods thereof

 #14 | 2016-09-29 ✅ Patent 9,809,551 granted on 2017-11-07
US20160280654A1
Chemistry; metallurgy

Solid forms of Ivacaftor and processes for the preparation thereof

 #15 | 2015-12-10 ✅ Patent 9,994,523 granted on 2018-06-12
US20150353490A1
Chemistry; metallurgy

Salts of Saxagliptin with organic acids

 #16 | 2015-10-01 ✅ Patent 9,376,419 granted on 2016-06-28
US20150274699A1
Chemistry; metallurgy

Solid forms of nilotinib hydrochloride

 #17 | 2015-08-13 ✅ Patent 9,260,438 granted on 2016-02-16
US20150225406A1
Chemistry; metallurgy

Solid forms of tofacitinib salts

 #18 | 2015-06-25 ✅ Patent 9,382,233 granted on 2016-07-05
US20150175583A1
Chemistry; metallurgy

Forms of vilazodone and processes for the preparation thereof

 #19 | 2007-04-12 ✅ Patent 7,410,985 granted on 2008-08-12
US20070082904A1
Chemistry; metallurgy

Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
AssigneeID:

407977 ⎘